Esperion Therapeutics, Inc.
US ˙ NasdaqGM ˙ US29664W1053

SecurityESPR / Esperion Therapeutics, Inc.
InstitutionPinnacle Associates Ltd
Latest Disclosed Ownership59,807 shares
Latest Disclosed Value $ 163,871
Pinnacle Associates Ltd reports 1.28% decrease in ownership of ESPR / Esperion Therapeutics, Inc.

On April 21, 2026 - Pinnacle Associates Ltd filed a 13F-HR form disclosing ownership of 59,807 shares of Esperion Therapeutics, Inc. (US:ESPR) valued at $163,871 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 60,581 shares of Esperion Therapeutics, Inc.. This represents a change in shares of -1.28% during the quarter. The current value of the position is $187,794 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 59,807 -774 -1.28 164 -27.23 0.0021
2026-02-05 2025-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 60,581 -524 -0.86 224 39.13 0.0028
2025-11-13 2025-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 61,105 0 0.00 162 168.33 0.0021
2025-08-04 2025-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 61,105 -320 -0.52 60 -31.82 0.0009
2025-05-06 2025-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 61,425 -750 -1.21 88 -35.29 0.0013
2025-02-14 2024-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 62,175 -221,080 -78.05 137 -83.92 0.0019
2024-10-25 2024-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 283,255 1,956 0.70 847 35.58 0.0144
2024-07-30 2024-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 281,299 -3,905 -1.37 624 -18.32 0.0098
2024-04-26 2024-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 285,204 1,949 0.69 764 -9.69 0.0120
2024-01-19 2023-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 283,255 -5,868 -2.03 847 198.94 0.0143
2023-10-24 2023-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 289,123 39,285 15.72 283 -18.44 0.0053
2023-07-27 2023-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 249,838 3,225 1.31 347 -11.48 0.0060
2023-05-05 2023-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 246,613 7,857 3.29 392 -73.64 0.0080
2023-02-01 2022-12-31 13F/A-1 ESPERION THERAPEUTICS INC NE COM 29664W105 238,756 -3,860 -1.59 1,487 -8.55 0.0324
2023-01-25 2022-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 244,206 1,590 1,675 0.0000
2022-11-01 2022-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 242,616 -14,618 -5.68 1,626 -0.61 0.0373
2022-08-02 2022-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 257,234 -2,549 -0.98 1,636 35.77 0.0357
2022-05-05 2022-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 259,783 3,980 1.56 1,205 -5.79 0.0213
2022-02-02 2021-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 255,803 -5,156 -1.98 1,279 -59.33 0.0221
2021-10-19 2021-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 260,959 -10,245 -3.78 3,145 -45.17 0.0580
2021-08-02 2021-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 271,204 4,193 1.57 5,736 -23.42 0.1037
2021-05-12 2021-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 267,011 -27,685 -9.39 7,490 -2.24 0.1428
2021-01-26 2020-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 294,696 38,213 14.90 7,662 -19.63 0.1556
2020-10-23 2020-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 256,483 -11,200 -4.18 9,533 -30.59 0.2264
2020-08-14 2020-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 267,683 -1,830 -0.68 13,735 61.63 0.3387
2020-05-13 2020-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 269,513 -46,376 -14.68 8,498 -54.88 0.2581
2020-02-03 2019-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 315,889 72,560 29.82 18,836 111.17 0.4125
2019-11-08 2019-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 243,329 55,780 29.74 8,920 2.23 0.2101
2019-08-05 2019-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 187,549 7,225 4.01 8,725 20.51 0.2043
2019-05-10 2019-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 180,324 -3,355 -1.83 7,240 -14.31 0.1636
2019-02-05 2018-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 183,679 -8,415 -4.38 8,449 -0.87 0.2181
2018-11-09 2018-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 192,094 -31,977 -14.27 8,523 -2.94 0.1768
2018-08-08 2018-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 224,071 -408,060 -64.55 8,781 -80.79 0.1807
2018-05-11 2018-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 632,131 -27,672 -4.19 45,722 5.25 0.8960
2018-02-12 2017-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 659,803 -58,010 -8.08 43,441 20.75 0.8346
2017-11-13 2017-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 717,813 -16,640 -2.27 35,977 5.85 0.6633
2017-08-09 2017-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 734,453 -36,165 -4.69 33,990 24.91 0.6533
2017-05-09 2017-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 770,618 654,138 561.59 27,211 1,766.32 0.5197
2017-02-10 2016-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 116,480 116,480 1,458 0.0294
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.